Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Nephrology
•
End stage kidney disease
•
Onconephrology
What is your approach to ESA use in patients with ESKD and active malignancy on treatment?
Answer from: at Community Practice
Patients can receive ESA’s and keep hgb goal at 10. Would discuss with oncologist and get clearance and after hematological workup is also attained.
Sign in or Register to read more
19104
Related Questions
What are your top takeaways from ASN 2023?
What adjustments do you make to a hemodialysis prescription for a patient with a recent stroke?
How soon after an intervention is done for peritoneal catheter inflow or outflow obstruction is it advisable to repeat the Kt/V?
Do you recommend avoiding ESAs in pregnant patients with anemia of chronic kidney disease who also have preeclampsia?
Do you take any different approaches for patients with end stage kidney disease who are about to be initiated on intermittent hemodialysis and have residual renal function?
Do you recommend continuing peritoneal dialysis in an ESKD patient on peritoneal dialysis who is diagnosed with encapsulating peritoneal sclerosis since abdominal symptoms may worsen when peritoneal dialysis is stopped?
How often do you check carnitine levels in your patients with end stage kidney disease on hemodialysis?
Should CAR-T therapy be considered for a kidney transplant patient with refractory PTLD?
What recommendations do you offer for patients who have a peritoneal dialysis catheter and who wish to swim?
Would you recommend initiating RRT in a patient with tumor lysis syndrome and a phosphorus of 9 mg/dl or more who does not have symptomatic hypocalcemia or other indications for dialysis?